Fill Finish Manufacturing Market Worth $25.7 billion | MarketsandMarkets™

CHICAGO, April 11, 2024 /PRNewswire/ -- Fill Finish Manufacturing Market in terms of revenue was estimated to be worth $16.7 billion in 2024 and is poised to reach $25.7 billion by 2029, growing at a CAGR of 8.9% from 2024 to 2029 according to a new report by MarketsandMarkets™.

The important factors impacting market growth are the growing applications in biotechnology & pharmaceutical industries and increasing adoption of pre-filled syringes for parenteral dosages. Rising demand for biologics and vaccines is also expected to drive market growth during the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609

Browse in-depth TOC on "Fill Finish Manufacturing Market"

495 - Tables
50 - Figures
440 - Pages

Fill Finish Manufacturing Market Scope:

Consumables segment had the largest estimated share of the fill finish manufacturing market.

Based on product, the fill finish manufacturing market is segmented into Consumables [Vials, {Glass vials, Plastic vials} Pre-fillable syringes (By Material {Glass and Plastic} and By components {Pre-fillable Syringe Systems & Components, Plunger Stoppers}, vial stoppers, cartridges, other consumables {Ampoules, bottles, bags, seals}] and Instruments (Instruments by System Type [Integrated, Standalone] and Instruments by Machine Type [Automated and Semi-automated]. The consumables segment accounted for the largest estimated share of the Fill-finish manufacturing market in 2023. The dominant share of this segment can primarily be attributed to the increased demand for parenteral drug delivery and rising shift towards biologics and biosimilars.

Contract Manufacturing Organizations (CMO's) take away the largest estimated share of end user segment.

Based on end users, the fill finish manufacturing market is classified into Contract Manufacturing Organizations (CMO's), pharmaceutical and biopharmaceutical companies and other end users (Contract Research Organizations [CROs] and academic research institutions). In 2023, the CMO's segment was predicted to account for the largest share of the global fill finish manufacturing market. The large share of this end user segment is due to the rising trend of outsourcing, cost efficiency offered by CMO's, and focus on core competencies.

During the forecast period, Europe exhibited lucrative market growth.

Europe accounted for the largest share of 36.3% of the global Fill finish manufacturing market, followed by North America and the Asia Pacific, with shares of 33.2% and 24.9%, respectively. The key factors driving market growth are established pharmaceutical industry, strategic location and infrastructure, and a collaborative ecosystem. The market in the Asia Pacific is expected to witness the highest growth rate of 9.5% during the forecast period, primarily due to the increasing adoption of self-administration and expansion initiatives by key players such as construction of new manufacturing facilities, capacity expansions, and investments in state-of-the-art equipment and technologies.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=6249609

Fill Finish Manufacturing Market Dynamics:

Drivers:

1. Rising demand for biologics and vaccines

Restraints:

1. High operational costs

Opportunities:

1. Technological advancements in fill finish solutions

Challenge:

1. Batch-to-batch variability in sterility

Key Market Players of Fill Finish Manufacturing Industry:

The global fill finish manufacturing markets comprises of many key market players competing for markets shares like Syntegon Technology GmbH (Germany), I.M.A. S.P.A. (Italy), BD (US), West Pharmaceutical Services, Inc. (US), Gerresheimer AG (Germany), AptarGroup, Inc. (US), Dätwyler Holding Inc. (Belgium), Berry Global, Inc. (US), Stevanato Group S.p.A. (Italy), OPTIMA (Germany), Bausch+Ströbel (Germany), Groninger & Co. Gmbh (Germany), SGD PHARMA (France), SCHOTT (Germany), Nipro Corporation (Japan), Bausch Advanced Technology Group (US) and Maquinaria Industrial Dara, Sl (Spain).

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80%, and Demand Side - 20%
• By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%

Recent Developments of Fill Finish Manufacturing Industry:

• In October 2023, Gerresheimer launched Gx Elite, a product line comprising glass injection vials aimed at enhancing both patient safety and production efficiency. The primary focus of this range is on delivering superior quality and enhanced shatter resistance.
• In October 2023, Datwyler launched its ready-for-sterilization (RFS) combi-seals designed for cartridges utilized in injection devices like pens and autoinjectors.
• In December 2023, Datwyler and Conserva UK collaborated to create a supply chain for pharmaceutical primary packaging within the UK market. This strategic partnership seeks to strengthen Datwyler's footprint in the UK, utilizing Conserva UK as the main interface for its esteemed customer network.

Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=6249609

Fill Finish Manufacturing Market - Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall fill finish manufacturing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing biotechnology & pharmaceutical industry applications, rising pre-filled syringes for parenteral dosages adoption and growing demand for biologics and vaccines), restraints (High operational costs), opportunities (Technological advancements in fill finish solutions) and challenges (Batch-to-batch variability in sterility) are influencing the growth of fill finish manufacturing market.
• Product Development/Innovation: Detailed insights on newly launched products of the fill finish manufacturing market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the fill finish manufacturing market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the fill finish manufacturing market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players include Syntegon Technology GmbH (Germany), I.M.A. S.P.A. (Italy), BD (US), West Pharmaceutical Services, Inc. (US), Gerresheimer AG (Germany), AptarGroup, Inc. (US), Dätwyler Holding Inc. (Belgium), Berry Global, Inc. (US), Stevanato Group S.p.A. (Italy), OPTIMA (Germany), Bausch+Ströbel (Germany), Groninger & Co. Gmbh (Germany), SGD PHARMA (France), SCHOTT (Germany), Nipro Corporation (Japan), Bausch Advanced Technology Group (US), and Maquinaria Industrial Dara, Sl (Spain), among others in the fill finish manufacturing market.

Related Reports:

Wearable Injectors Market - Global Forecasts to 2029

Pharmaceutical Packaging Equipment Market - Global Forecasts to 2028

Empty Capsules Market - Global Forecasts to 2028

Autoinjectors Market - Global Forecasts to 2028

Active Pharmaceutical Ingredient Market - Global Forecasts to 2027

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/fill-finish-manufacturing-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/fill-finish-manufacturing.asp

Logo: https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg